Pictet & Cie (Europe) Sa Gilead Sciences, Inc. Transaction History

Pictet & Cie (Europe) Sa

$4.19 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $155,820 - $177,735	-2,050 Reduced 13.6%	13,025 $1 Million
Q1 2023 May 01, 2023	SELL	$77.31 - $88.08 $73,444 - $83,676	-950 Reduced 5.93%	15,075 $1.25 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $89,310 - $102,015	1,500 Added 10.33%	16,025 $989 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $173,760 - $217,740	3,000 Added 26.03%	14,525 $864,000
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $652,891 - $743,938	11,525 New	11,525 $671,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $635,434 - $737,856	-8,784 Closed	0 $0
Q1 2020 Apr 30, 2020	SELL	$62.63 - $80.22 $1.91 Million - $2.44 Million	-30,449 Reduced 77.61%	8,784 $657,000
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $84,419 - $92,858	-1,370 Reduced 3.37%	39,233 $2.55 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $75,012 - $82,800	-1,200 Reduced 2.87%	40,603 $2.57 Million
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $74,244 - $83,256	1,200 Added 2.96%	41,803 $2.82 Million
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $176,897 - $198,171	2,829 Added 7.49%	40,603 $2.64 Million
Q4 2018 Jan 31, 2019	BUY	$60.54 - $79.0 $810,025 - $1.06 Million	13,380 Added 54.85%	37,774 $2.36 Million
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $70,210 - $77,736	985 Added 4.21%	24,394 $1.88 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $274,572 - $320,277	-4,232 Reduced 15.31%	23,409 $1.66 Million
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $344,314 - $419,757	4,727 Added 20.63%	27,641 $2.08 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $206,406 - $242,291	-2,901 Reduced 11.24%	22,914 $1.64 Million
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $440,015 - $521,537	6,102 Added 30.95%	25,815 $2.09 Million
Q2 2017 Aug 09, 2017	BUY	N/A	19,713	19,713 $1.4 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.

Account